OSTEOAMP® vs Infuse™: Important news for your clients

New data has affirmed that OSTEOAMP is a viable substitute for Infuse™ (rhBMP-2) for single- and multilevel lumbar fusion.54

Matthew J. McGirt, MD, of Carolina NeuroSurgery & Spine Associates, led a retrospective analysis of outcomes involving patients who had transforaminal and posterior lumbar interbody fusion with either OSTEOAMP (330 patients) or Infuse (330 patients).54

The study concludes that OSTEOAMP “is a viable substitute for rhBMP-2” for single- and multilevel lumbar fusion.

 

More results of the study:54

  • There were no significant baseline differences between 330 OSTEOAMP and 330 rhBMP-2 cases.
  • Perioperative morbidity and 90-day hospital readmission did not significantly differ between OSTEOAMP and the rhBMP-2 cases.
  • The overall fusion rate at 2 years was similar between groups.
  • Both groups showed significant and equivalent improvement in patient-reported outcome measures (PROMs) from baseline to 12-month follow-up.

 

Order copies for your clients

Use this form to order digital/print copies of McGirt et al, or to learn more about OSTEOAMP.

"*" indicates required fields

yes
privacy*
This field is for validation purposes and should be left unchanged.

 

About OSTEOAMP and OSTEOAMP Select

Available in six formats to meet your unique surgical needs, OSTEOAMP and OSTEOAMP Select are differentiated allograft bone graft substitutes uniquely processed with bone and bone marrow. This process is designed to retain essential endogenous growth factors that align with and support each phase of the body’s natural bone healing process and has been shown to retain up to 23 different growth factors that support new bone formation.†‡1

*Dr. McGirt is a paid consultant of Bioventus.
†In vitro performance may not be predictive of performance in humans.
‡OSTEOAMP may be used in situations where an autograft is appropriate. It should be restricted to homologous use for the repair, replacement, or reconstruction of musculoskeletal defects.